|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.31 USD | +1.69% |
|
+1.90% | -36.09% |
| 11-19 | DexCom, OURA Partner to Combine Glucose, Biometric Data Via New Integration | MT |
| 11-19 | Smart ring maker Oura valued at over $5 billion after Dexcom funding | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 30.98B 29.52B 27.46B 24.5B 43.59B 2,625B 47.97B 341B 127B 1,076B 116B 114B 4,621B | P/E ratio 2024 * |
51x | P/E ratio 2025 * | 40.7x |
|---|---|---|---|---|---|
| Enterprise value | 32.46B 30.93B 28.78B 25.67B 45.67B 2,751B 50.27B 357B 133B 1,127B 122B 119B 4,842B | EV / Sales 2024 * |
8.08x | EV / Sales 2025 * | 6.89x |
| Free-Float |
95.24% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: DexCom, Inc.
More recommendations
More press releases
More news
| 1 day | +1.69% | ||
| 1 week | +1.90% | ||
| Current month | +1.69% | ||
| 1 month | +12.74% | ||
| 3 months | +14.38% | ||
| 6 months | -33.22% | ||
| Current year | -36.09% |
1 week
77.18
80.18
1 month
67.7080.18
Current year
62.34142.00
1 year
62.34142.00
3 years
62.34144.96
5 years
45.52164.86
10 years
10.66164.86
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 31/12/2014 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18/03/2021 |
| Chief Tech/Sci/R&D Officer | 47 | 30/09/2022 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 66 | 29/07/2018 |
Eric Topol
BRD | Director/Board Member | 69 | 08/07/2009 |
Nick Augustinos
BRD | Director/Board Member | 65 | 19/11/2009 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.46% | 20 M€ | +16.14% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.69% | +1.90% | -31.99% | -43.37% | 30.46B | ||
| -1.65% | -1.12% | +11.37% | -9.01% | 206B | ||
| 0.00% | +0.92% | +8.19% | -19.33% | 111B | ||
| +0.41% | -1.18% | -6.48% | -7.90% | 64.16B | ||
| -0.67% | +2.31% | +22.43% | +115.78% | 48.62B | ||
| +2.51% | +2.27% | +22.08% | +9.28% | 44.52B | ||
| +0.39% | -0.52% | +31.09% | +33.33% | 30.01B | ||
| -0.93% | +0.89% | -8.28% | -26.23% | 23.59B | ||
| -1.43% | -0.41% | -6.33% | -10.11% | 22.31B | ||
| -0.09% | +1.27% | +7.54% | -0.80% | 21.62B | ||
| Average | +0.23% | +0.71% | +4.96% | +4.16% | 60.23B | |
| Weighted average by Cap. | +0.32% | +0.61% | +7.80% | +0.58% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 4.02B 3.83B 3.56B 3.18B 5.65B 340B 6.22B 44.21B 16.41B 139B 15.09B 14.75B 599B | 4.6B 4.38B 4.08B 3.64B 6.47B 390B 7.12B 50.64B 18.8B 160B 17.28B 16.89B 686B |
| Net income | 634M 604M 562M 501M 891M 53.69B 981M 6.98B 2.59B 22B 2.38B 2.33B 94.51B | 780M 743M 691M 617M 1.1B 66.07B 1.21B 8.58B 3.19B 27.07B 2.93B 2.86B 116B |
| Net Debt | 1.48B 1.41B 1.32B 1.17B 2.09B 126B 2.3B 16.34B 6.06B 51.53B 5.58B 5.45B 221B | 714M 680M 633M 565M 1B 60.5B 1.11B 7.86B 2.92B 24.79B 2.68B 2.62B 106B |
More financial data
* Estimated data
Employees
9,550
Calendar
05/02/2025
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/12/24 | 79.31 $ | +1.69% | 3,277,652 |
| 29/11/24 | 77.99 $ | -0.14% | 1,510,418 |
| 27/11/24 | 78.10 $ | +0.21% | 2,003,316 |
| 26/11/24 | 77.94 $ | +0.14% | 4,142,028 |
Delayed Quote Nasdaq, December 02, 2024 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
79.31USD
Average target price
95.26USD
Spread / Average Target
+20.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition